Securities Announcement No.: Sichuan Jinlu Group Co.Ltd(000510) 260006
Announcement of abnormal fluctuations in stock trading
The company and all members of the board of directors guarantee that the contents of the announcement are true, accurate and complete without false records, misleading statements or major omissions.
1、 Introduction to abnormal fluctuations in stock trading
Xi’An International Medical Investment Company Limited(000516) (hereinafter referred to as the “company”) (Securities abbreviation: St Guoyi, securities code: Xi’An International Medical Investment Company Limited(000516) ) the deviation of closing price decline for three consecutive trading days on March 9, March 10 and March 11, 2022 has reached 12.60%. According to the relevant provisions of Shenzhen Stock Exchange, it belongs to abnormal fluctuation of stock trading.
2、 The company pays attention to and verifies the situation
In view of the abnormal fluctuation of the company’s shares, the company has conducted necessary verification on relevant matters, and the relevant information is explained as follows:
1. Xi’an high tech hospital and Xi’an Xi’An International Medical Investment Company Limited(000516) Central Hospital subordinate to the company have been closed for rectification for three months since January 13, 2022 according to the requirements of Xi’an Health Commission. At present, the above two hospitals are closing for rectification on schedule.
2. The company disclosed the announcement on signing the equity transfer framework agreement of subsidiaries in the securities times, China Securities Journal, Shanghai Securities News, securities daily and cninfo on March 9, 2022, The company signed the framework agreement on equity transfer of Shangluo Xi’An International Medical Investment Company Limited(000516) Central Hospital Co., Ltd. with Shangluo transportation investment and Construction Co., Ltd. on March 7, 2022, and plans to transfer 99% of the equity of Shangluo Xi’An International Medical Investment Company Limited(000516) Central Hospital Co., Ltd. at a price, which is conducive to the company’s improvement of business layout and optimization of asset structure, However, as the agreement signed this time is only a framework agreement of intent, the specific transaction scheme needs to be further negotiated and determined.
3. The company has not found any unpublished material information that may or has had a great impact on the stock trading price of the company reported by the public media recently.
4. The company, its controlling shareholders and actual controllers do not have any major events that should be disclosed but not disclosed, nor do they have any major events in the planning stage other than those already disclosed.
5. The controlling shareholder and actual controller of the company did not buy or sell the company’s shares during the abnormal fluctuation of the company’s stock trading.
6. There is no need to correct or supplement the information disclosed by the company in the early stage.
3、 Whether there is a description of the information that should be disclosed but not disclosed
The board of directors of the company confirms that the company has no undisclosed matters or planning, negotiation, intention, agreement, etc. related to the matters that should be disclosed in accordance with the relevant provisions of the Listing Rules of Shenzhen Stock Exchange; The board of directors has not been informed that the company has undisclosed information that has a great impact on the trading price of the company’s shares that should be disclosed in accordance with the stock listing rules of Shenzhen Stock Exchange and other relevant provisions; The information disclosed by the company in the early stage does not need to be corrected or supplemented.
4、 Necessary risk tips
1. After self-examination, the company does not violate the fair disclosure of information.
2. The company disclosed the 2021 annual performance forecast (Announcement No.: 2022005) on January 29, 2022. As of the disclosure date of this announcement, the above performance is not expected to be corrected. The specific financial data of the company in 2021 shall be subject to the annual report of the company in 2021.
3. The company solemnly reminds investors: securities times, China Securities News, Shanghai Securities News, securities daily and cninfo（ http://www.cn.info.com.cn. ）As the information disclosure media designated by the company, all information of the company shall be subject to the information published in the above designated media. Investors are invited to invest rationally and pay attention to risks.
It is hereby announced.
Xi’An International Medical Investment Company Limited(000516) board of directors
March 14, 2002
